CTIS, the Reporting Member State, and the Single Portal

Part of Regulatory Affairs and the Jurisdiction Map: The European Union under CTR 536/2014.

About 5 minutes. Free, in your language, no account needed.

Why this matters

The Regulation's single submission needs somewhere to be submitted, and that place is the Clinical Trials Information System. It is not a filing cabinet. It is the mechanism through which the coordinated assessment actually happens, and it is also, substantially, a public register.

That second property changes how you write. Material submitted through the system is subject to defined transparency rules, and content that a sponsor would previously have treated as internal is now published on a schedule. Writing a submission as though it were private correspondence is a mistake with a long tail.

How the coordinated assessment runs through it

The sponsor submits once, identifying every member state concerned and proposing a reporting member state.

The reporting member state leads Part I. It produces the draft assessment, coordinates the input of the other member states concerned, consolidates their comments, and issues the single Part I conclusion.

Each member state concerned assesses Part II for itself, in parallel, against its own national requirements.

A single decision per member state results, combining the Part I conclusion with that state's own Part II conclusion. This is the crucial mechanic: a sponsor receives a decision from each member state, and each of those decisions incorporates the shared Part I outcome.

Requests for information are consolidated. Rather than each member state asking separately, the questions come together, and the sponsor answers once. This is a large part of the efficiency gain, and it also means a single missed question stops the whole application rather than one country's.

Adding a member state later

A trial frequently needs to expand. The Regulation provides for adding a member state after the initial authorization, and the added state assesses both the existing Part I conclusion and its own Part II.

Two consequences matter operationally. First, the addition is its own procedure with its own clock, so a country added in month eight does not inherit the original timeline. Second, the added member state reviews Part I as it currently stands, including every modification authorized since, which means a study with a complicated amendment history presents a larger package than the original application did.

Teams plan expansions as though they were a formality. They are a submission.

Transparency, and writing accordingly

Information submitted through the system is published according to defined rules and timelines, with provisions allowing deferral in defined circumstances such as protecting commercially confidential information or personal data.

The practical discipline is straightforward. Write every submitted document as though it will be read by a competitor, a journalist, a patient advocacy group and a future inspector, because some of them will read it. Keep genuinely confidential material to the fields designed for it rather than scattering it through narrative text where it cannot be selectively withheld. And never write a cover letter that says something you would not defend publicly.

In practice

A sponsor's regulatory lead prepares a response to a consolidated request for information covering questions from four member states.

Two questions are scientific and belong to Part I. Two are national: one about a consent form's language, one about site suitability. The temptation is to answer all four in one document, because they arrived together.

That is the wrong shape. The Part I answers become part of the coordinated assessment and bind across every concerned member state. The Part II answers concern one member state each and should not be presented as though they modify the shared position.

The lead separates them, answers the Part I questions in terms that hold for every member state, and answers each Part II question to its own state. A single mixed document risks a national commitment becoming part of the shared assessment, which would then apply in countries that never asked for it.

That is the specific error worth naming: a concession made to one member state, drafted into the shared part, silently becomes a commitment everywhere.

What this looks like when it goes wrong

A sponsor misses the deadline for responding to a consolidated request for information.

Because the assessment is coordinated, the consequence is not one country's delay. The application lapses across every member state concerned, and the sponsor must resubmit.

Nine countries lose their place in a queue because one response was late. Under the old country-by-country arrangement, a missed deadline cost one country. Under a coordinated procedure the efficiency runs both directions, and the response deadline deserves the protection you would give to a safety report clock.

Key takeaways